Gastric Cancer Education · Surgery · Chemo · HER2 · Immunotherapy · Nutrition

Stomach Cancer Treatment Education

Stomach cancer treatment depends on stage, tumor location, whether the tumor can be removed, lymph-node involvement, biomarker results, symptoms, nutrition status, overall health and treatment goals. Options may include endoscopic resection, subtotal or total gastrectomy, lymph-node removal, chemotherapy, radiation therapy, targeted therapy, immunotherapy, clinical trials, palliative care and nutrition support.

Educational information only. This page does not provide diagnosis, treatment recommendations or medical advice. Treatment decisions must be made with qualified healthcare professionals.
Open Treatment Schema View Treatment Options
Surgery
Chemo
HER2
Immuno
Nutrition
Treatment Planning

How stomach cancer treatment is planned

Treatment planning usually involves a multidisciplinary team. The care plan may combine local treatment for the stomach tumor with systemic treatment that reaches cancer cells throughout the body.

01

Stage and resectability

The team determines whether the tumor is early, locally advanced, metastatic, removable by surgery, or better managed with systemic and supportive care.

02

Biomarker testing

HER2, MSI/MMR, PD-L1, EBV and CLDN18.2 results may influence advanced or metastatic treatment discussions.

03

Nutrition and symptom needs

Weight loss, appetite loss, anemia, vomiting, swallowing problems and nutrition status can affect treatment timing and support planning.

Treatment Schema

Stomach cancer treatment map

This schema organizes treatment concepts from diagnosis and staging to local treatment, systemic therapy, biomarker-directed care and long-term support.

Stage & Workup TNM · CT/PET · EUS · Laparoscopy · Nutrition status
Local Treatment Endoscopic resection · Subtotal gastrectomy · Total gastrectomy
Systemic Therapy Chemotherapy · Perioperative therapy · Immunotherapy
Biomarker Strategy HER2 · MSI/MMR · PD-L1 · CLDN18.2 · VEGF
Support & Follow-up Nutrition · Anemia · Symptoms · Surveillance · Survivorship
Treatment Strategy
Surgery Chemo HER2 PD-1 CLDN18.2
Treatment Options

Main stomach cancer treatment approaches

More than one treatment type is often used. ACS notes that even when surgery is an option, it is rarely the only treatment, and chemotherapy, immunotherapy, radiation therapy or newer targeted drugs may also be part of care. :contentReference[oaicite:1]{index=1}

Endoscopic resection

Selected very early stomach cancers limited to superficial layers may be removed through an endoscope without open surgery.

Selected very early disease

Subtotal gastrectomy

Removes part of the stomach, usually when the tumor location allows preservation of some stomach tissue.

Surgical local control

Total gastrectomy

Removes the entire stomach when tumor location, size or extent requires complete stomach removal.

Complex surgical treatment

Lymph-node removal

Regional lymph nodes are often removed or assessed during surgery because nodal involvement is central to staging.

Staging and local control

Chemotherapy

Chemotherapy may be used before surgery, after surgery, with radiation, or for advanced disease. ACS notes most people receive chemotherapy as part of treatment. :contentReference[oaicite:2]{index=2}

Systemic treatment

Radiation therapy

Radiation may be used with chemotherapy in selected settings, after surgery in some cases, or to help control symptoms.

Local-regional treatment

Targeted therapy

Targeted drugs may be used when tumors have specific markers or features, such as HER2, VEGF-related pathways or CLDN18.2 expression.

Biomarker-directed context

Immunotherapy

Immunotherapy may be used in selected advanced or recurrent gastric cancers, depending on biomarkers and treatment setting.

Immune checkpoint context
Treatment by Stage

Treatment concepts by stomach cancer stage

Treatment varies by stage and by whether the cancer is localized, locally advanced, metastatic, recurrent, or causing symptoms that need relief.

Early
Very early-stage disease

Selected superficial tumors may be treated with endoscopic resection or surgery depending on depth, pathology and risk features.

Local
Localized resectable disease

Surgery is often central. Chemotherapy before and/or after surgery may be discussed depending on stage and fitness.

III
Locally advanced disease

Treatment may combine chemotherapy, surgery and sometimes radiation, depending on resectability and multidisciplinary review.

IV
Metastatic disease

Treatment often focuses on systemic therapy, biomarker-directed options, symptom relief, nutrition support, clinical trials and palliative care.

Care Path
Early Surgery Chemo Targeted Support
Surgery & Nutrition

Gastrectomy changes digestion and nutrition

Surgery may remove part or all of the stomach. After gastrectomy, eating patterns, vitamin needs, weight maintenance, reflux symptoms, dumping symptoms, iron, B12 and nutrition support may become important parts of recovery.

Smaller meals

Many patients need smaller, more frequent meals after stomach surgery because the stomach reservoir is reduced or removed.

Vitamin and mineral monitoring

B12, iron, calcium, vitamin D and overall protein-energy intake may need monitoring.

Dumping symptoms

Rapid food movement into the intestine can cause sweating, cramping, diarrhea, dizziness or rapid heartbeat after eating.

Dietitian support

A specialist dietitian can help manage weight loss, meal timing, supplements and long-term nutrition planning.

Biomarker Therapy
HER2 MSI PD-L1 CLDN18.2
Advanced or Metastatic Disease

Systemic therapy and biomarker context

Targeted therapy drugs are designed to target specific features, changes or substances in or on cancer cells, and can sometimes be used alone or with chemotherapy depending on the situation. :contentReference[oaicite:3]{index=3} Immunotherapy works by helping the immune system destroy cancer cells more effectively, but it can also cause immune-related side effects. :contentReference[oaicite:4]{index=4}

HER2-directed therapy

HER2-positive gastric or gastroesophageal junction tumors may be evaluated for HER2-directed treatment combinations.

PD-1 / PD-L1 immunotherapy

PD-L1 and MSI/MMR results may help guide immunotherapy discussions in advanced disease settings.

CLDN18.2-directed therapy

CLDN18.2 expression is increasingly relevant in gastric cancer biomarker-directed treatment planning.

VEGF / angiogenesis targeting

Anti-angiogenic approaches may be considered in selected advanced gastric cancer settings.

Side Effects & Support

Common treatment side-effect topics to discuss

Side effects depend on the treatment type, stage, nutrition status, previous treatment, overall health and personal goals.

After surgery

Ask about infection, bleeding, leakage, pain, weight loss, reflux, dumping syndrome, B12, iron and meal planning.

During chemotherapy

Ask about nausea, appetite loss, neuropathy, fatigue, diarrhea, mouth sores, infection risk and blood counts.

During radiation

Ask about nausea, fatigue, skin irritation, diarrhea, appetite effects and how symptoms will be managed.

With immunotherapy

Ask about immune-related symptoms affecting skin, lungs, bowels, liver, hormones, kidneys or other organs.

Care Team Questions

Questions to ask about stomach cancer treatment

Select a topic to reveal practical questions for treatment-planning visits.

Treatment plan questions

  • What is my TNM stage?
  • Is the cancer removable with surgery?
  • Do I need chemotherapy before or after surgery?
  • Is the goal cure, control, symptom relief or recurrence management?

Clinical trials may be part of the treatment conversation

Gastric cancer trials may study perioperative therapy, immunotherapy combinations, HER2-directed strategies, CLDN18.2-targeted therapy, anti-angiogenic approaches, radiation combinations, symptom control and nutrition interventions.

Read Treatment FAQ
Simple Summary

Stomach cancer treatment in simple terms

Stomach cancer treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, clinical trials, symptom support and nutrition care.

What are common stomach cancer treatments?

Common treatments include endoscopic resection for selected very early tumors, gastrectomy, lymph-node removal, chemotherapy, radiation therapy, targeted therapy, immunotherapy and supportive care.

Why are biomarkers important?

Biomarkers such as HER2, MSI/MMR, PD-L1 and CLDN18.2 can help the care team discuss targeted therapy or immunotherapy options in selected treatment settings.

Why is nutrition support important?

Stomach cancer and stomach surgery can affect appetite, weight, digestion, vitamin absorption and eating patterns, so nutrition support is often important.

FAQ

FAQ: Stomach Cancer Treatment Education

Clear answers to common stomach cancer treatment questions.

What are the main treatment options for stomach cancer?

Main treatment options may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, clinical trials and supportive care.

Is stomach cancer always treated with surgery?

No. Surgery may be central for removable localized disease, but metastatic, unresectable or recurrent disease may be treated mainly with systemic therapy, symptom support and palliative care.

What is gastrectomy?

Gastrectomy is surgery to remove part of the stomach or the entire stomach, depending on tumor location and extent.

When are targeted therapy or immunotherapy used?

Targeted therapy or immunotherapy may be used in selected advanced, metastatic or recurrent stomach cancers depending on biomarkers, prior therapy and treatment goals.

Is this page medical advice?

No. This page is educational only and does not replace consultation with a qualified healthcare professional.

References

Scientific References

Authoritative sources used to support this stomach cancer treatment education page.

  1. National Cancer Institute. Stomach cancer treatment overview.
  2. National Cancer Institute. Gastric cancer treatment PDQ.
  3. American Cancer Society. Treating stomach cancer.
  4. American Cancer Society. Chemotherapy, targeted therapy and immunotherapy for stomach cancer.
  5. Clinical literature on gastrectomy, perioperative chemotherapy, HER2, MSI/MMR, PD-L1, CLDN18.2 and advanced gastric cancer treatment.